Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

940 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels.
Moia R, Talotta D, Terzi di Bergamo L, Almasri M, Dondolin R, Salehi M, Cosentino C, Soscia R, Della Starza I, Bruscaggin A, Andorno AG, Mercalli F, Cresta S, Bomben R, Bittolo T, Vit F, Bulian P, Zucchetto A, Bruna R, Rivolta GM, Schipani M, Secomandi E, Kogila S, Bellia M, Mouhssine S, Nabki J, Al Deeban B, Ghanej J, Cividini L, Maher N, Melle F, Motta G, Leutner M, Lorenzi A, Mahmoud AM, Al Essa W, Deambrog C, Rasi S, Petrucci L, Boldorini R, Di Rocco A, Del Giudice I, Spina M, Palazzolo S, Canal F, Canzonieri V, Martelli M, Pileri SA Professor, Gattei V, Foà R, Rossi D, Gaidano G. Moia R, et al. Among authors: foa r. Blood Adv. 2025 Jan 18:bloodadvances.2024014136. doi: 10.1182/bloodadvances.2024014136. Online ahead of print. Blood Adv. 2025. PMID: 39825831
Tyrosine kinase inhibitor discontinuation in non-allografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study.
Dragani M, Ansuinelli M, Papayannidis C, Fracchiolla N, Cardinali V, Cedrone M, Guolo F, Perrone S, Salutari P, Todisco E, Foà R, Chiaretti S. Dragani M, et al. Among authors: foa r. Haematologica. 2025 Jan 9. doi: 10.3324/haematol.2024.286325. Online ahead of print. Haematologica. 2025. PMID: 39781617 Free article.
Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma.
Soscia R, Assanto GM, Starza ID, Moia R, Talotta D, Bellomarino V, Bellissimo T, Antonacci M, Petrucci L, Gaidano G, Guarini A, Martelli M, Di Rocco A, Foà R, Del Giudice I. Soscia R, et al. Among authors: foa r. Haematologica. 2024 Dec 19. doi: 10.3324/haematol.2024.286331. Online ahead of print. Haematologica. 2024. PMID: 39704164 Free article.
How I treat adult Ph+ ALL.
Chiaretti S, Foà R. Chiaretti S, et al. Among authors: foa r. Blood. 2025 Jan 2;145(1):11-19. doi: 10.1182/blood.2023023152. Blood. 2025. PMID: 39172753 Review.
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study.
Lazzarotto D, Cerrano M, Papayannidis C, Chiaretti S, Mosna F, Fracchiolla N, Zappasodi P, Imbergamo S, Del Principe MI, Lunghi M, Lussana F, Piccini M, Fumagalli M, Dargenio M, Salutari P, Forghieri F, Da Molin TG, Bonifacio M, Olivi M, Giglio F, Trappolini S, Leoncin M, Mule A, Delia M, Pasciolla C, Grimaldi F, Cambo B, Santoro L, Guolo F, Minetto P, Defina M, Chiusolo P, Fanin M, Mauro E, Aprile L, Mazzone C, Trastulli F, Ciccone M, De Gobbi M, Cignetti A, De Bellis E, Mancini V, Piciocchi A, Vignetti M, Marsili G, Starza ID, Fanin R, Luppi M, Ferrara F, Pizzolo G, Bassan R, Foa R, Candoni A. Lazzarotto D, et al. Among authors: foa r. Haematologica. 2025 Jan 1;110(1):55-67. doi: 10.3324/haematol.2024.285638. Haematologica. 2025. PMID: 39157875 Free PMC article.
Ponatinib alone or with chemo-immunotherapy in heavily pre treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study.
Kaiser F, Lunghi M, Cardinali D, Bellomarino V, Beldinanzi M, Starza ID, Malfona F, Basilico CM, Defina M, Mastaglio S, Giglio F, Lazzarotto D, Salutari P, Piccini M, Cardinali V, Pierini A, Fracchiolla NS, Di Biase F, Annunziata M, Di Trani M, Foa R, Chiaretti S. Kaiser F, et al. Among authors: foa r. Haematologica. 2024 Dec 1;109(12):4095-4099. doi: 10.3324/haematol.2024.285258. Haematologica. 2024. PMID: 39086308 Free PMC article. No abstract available.
CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience.
Bomben R, Zucchetto A, Laureana R, Chiarenza A, Olivieri J, Tissino E, Rossi FM, Vit F, Bittolo T, Papotti R, Pozzo F, Gaglio A, Degan M, Polesel J, Marasca R, Visentin A, Moia R, Innocenti I, Vitale C, Murru R, Varettoni M, Tafuri A, Zaja F, Postorino M, Martino EA, Condoluci A, Rossi D, Cuneo A, Di Raimondo F, Sportoletti P, Del Giudice I, Foà R, Mauro FR, Coscia M, Laurenti L, Gaidano G, Trentin L, Principe MID, Gentile M, Gattei V. Bomben R, et al. Among authors: foa r. Hemasphere. 2024 Jul 15;8(7):e128. doi: 10.1002/hem3.128. eCollection 2024 Jul. Hemasphere. 2024. PMID: 39011128 Free PMC article. No abstract available.
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial.
Pulsoni A, Ferrero S, Tosti ME, Luminari S, Dondi A, Cavallo F, Merli F, Liberati AM, Cenfra N, Renzi D, Zanni M, Boccomini C, Ferreri AJM, Rattotti S, Zilioli VR, Bolis SA, Bernuzzi P, Musuraca G, Gaidano G, Perrone T, Stelitano C, Tucci A, Corradini P, Bigliardi S, Re F, Cencini E, Mannarella C, Mannina D, Celli M, Tani M, Annechini G, Assanto GM, Grapulin L, Guarini A, Cavalli M, De Novi LA, Bomben R, Ciabatti E, Genuardi E, Drandi D, Della Starza I, Arcaini L, Ricardi U, Gattei V, Galimberti S, Ladetto M, Foà R, Del Giudice I. Pulsoni A, et al. Among authors: foa r. Lancet Haematol. 2024 Jul;11(7):e499-e509. doi: 10.1016/S2352-3026(24)00143-1. Lancet Haematol. 2024. PMID: 38937025 Clinical Trial.
940 results